Oral propranolol for retinopathy of prematurity: risks, safety concerns, and perspectives.
about
Novelty in hypertension in children and adolescents: focus on hypertension during the first year of life, use and interpretation of ambulatory blood pressure monitoring, role of physical activity in prevention and treatment, simple carbohydrates andCardiovascular drugs in the treatment of infantile hemangiomaPharmacologic interventions for the prevention and treatment of retinopathy of prematurityIGF-I in the clinics: Use in retinopathy of prematurityTreatment of infantile haemangiomas: recommendations of a European expert group.Ocular Safety of Intravitreal Propranolol and Its Efficacy in Attenuation of Choroidal Neovascularization.The Efficacy of Propranolol in Retinopathy of Prematurity and its Correlation with the Platelet Mass Index.Safety and Efficacy of Propranolol in Comparison With Combination of Fentanyl and Ketamine as Premedication in Cataract Surgery Under the Topical AnesthesiaInfantile hemangiomas, retinopathy of prematurity and cancer: a common pathogenetic role of the β-adrenergic system.Study protocol: safety and efficacy of propranolol 0.2% eye drops in newborns with a precocious stage of retinopathy of prematurity (DROP-ROP-0.2%): a multicenter, open-label, single arm, phase II trial.Catecholamines facilitate VEGF-dependent angiogenesis via β2-adrenoceptor-induced Epac1 and PKA activation.Retinopathy of prematurity: Risk factors and variability in Canadian neonatal intensive care units.Blood Pressure Monitoring During the Induction and Maintenance Period of Propranolol Therapy for Complicated Infantile Hemangiomas: A Prospective Study of 109 Infants.Adverse Events in Young and Preterm Infants Receiving Topical Timolol for Infantile Hemangioma.Norepinephrine promotes tumor microenvironment reactivity through β3-adrenoreceptors during melanoma progressionThe Beta Adrenergic Receptor Blocker Propranolol Counteracts Retinal Dysfunction in a Mouse Model of Oxygen Induced Retinopathy: Restoring the Balance between Apoptosis and Autophagy.Propranolol 0.1% eye micro-drops in newborns with retinopathy of prematurity: a pilot clinical trial.Blood flow assessed by color Doppler imaging in retinopathy of prematurity.The progress of prophylactic treatment in retinopathy of prematurity.Assessment of WINROP algorithm as screening tool for preterm infants in Manitoba to detect retinopathy of prematurity.Oral propranolol for prevention of threshold retinopathy of prematurity (ROPROP): protocol of a randomised controlled trial
P2860
Q26740021-8CB0B7FF-B230-4B4C-AA20-9D41ADD7AF10Q26769978-A778383C-E1A1-46A9-988D-7F82AF722FB8Q26772889-D1E18F4D-F010-4188-9E71-AB6F67FEF5E8Q28070089-90CAB957-F115-4991-B2B6-7E327AEB24E2Q35645474-09FA1CA8-B698-45BF-BCCB-3872B6993F46Q35882658-C9DDB279-C6D3-47B6-ACBD-FCFAC0C37C39Q36040633-DB60CBE5-6563-49C5-AD1A-931CAB5A2195Q36718088-2C3C3D01-9EB8-4369-BECF-103D0B89FE00Q38293740-B4EB9FE7-69AE-403A-9374-5210B190EC60Q38373964-40C79028-7DB5-4DAA-826F-A4F6D242A6E5Q38781876-29035663-37E3-4E8B-A637-22C0CAAEC4D9Q40409839-0DED2377-B836-4AE7-B5C1-AD3445109207Q40517442-B08F0ABE-8943-4BD6-A5B6-F5551465E53DQ40725867-A7AFA4E5-0000-403D-8073-39E43F51DD29Q42434242-A812C066-5E12-42ED-857B-E1CC0B2E65C0Q47708800-3E2756A5-3122-4946-BA0F-4F5A7F40790DQ51425178-641E5151-7ACE-4A55-8ACD-9D7878F48582Q52866967-2614C1D7-9706-4E71-BC21-366ED1E622CFQ54999086-DC6FBBD5-8D73-48DB-9DC4-EE04E48D8023Q55355197-5805173A-9D76-4FD9-9260-0A1945EDC801Q56527442-AA8A631D-DEC0-4E62-9B41-78E2571FC716
P2860
Oral propranolol for retinopathy of prematurity: risks, safety concerns, and perspectives.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Oral propranolol for retinopat ...... ty concerns, and perspectives.
@en
Oral propranolol for retinopat ...... ty concerns, and perspectives.
@nl
type
label
Oral propranolol for retinopat ...... ty concerns, and perspectives.
@en
Oral propranolol for retinopat ...... ty concerns, and perspectives.
@nl
prefLabel
Oral propranolol for retinopat ...... ty concerns, and perspectives.
@en
Oral propranolol for retinopat ...... ty concerns, and perspectives.
@nl
P2093
P50
P1476
Oral propranolol for retinopat ...... ty concerns, and perspectives.
@en
P2093
Agostino La Torre
Gabriella Araimo
Gloria Cristofori
Maria Luisa Della Bona
Massimo Dal Monte
Paola Bagnoli
Patrizio Fiorini
Pina Fortunato
Sandra Furlanetto
Silvia Osnaghi
P304
1570-1577.e6
P356
10.1016/J.JPEDS.2013.07.049
P407
P577
2013-09-18T00:00:00Z